is trulicity a glp-1 receptor agonists – Peripheral Brain Glucagon-like Peptide-1 (GLP-1) AGONIST -
Description
PMID: 26371721 Triplitt C, Chiquette E (2003): Exenatide: from the Gila monster to the pharmacy

This work was supported by the Lundbeck Foundation (fellowship R238-2016-2859), the BioInnovation Institute (grant number NNF20OC0063538) and the Novo Nordisk Foundation (grant numbers NNF17OC0026114 and NNF22OC0073778)

Participants received weekly injections of survodutide at doses of 3.6 milligrams or 6.0 milligrams, or a placebo, over nearly a year and a half

This is largely attributed to glucagon suppression and slow gastric emptying
